Case Study: GlaxoSmithKline achieves safer global production with Microshare’s Universal Contact Tracing wearables

GlaxoSmithKline avoids millions in weekly shutdown costs with Microshare

GlaxoSmithKline, a major pharmaceutical company, faced the significant challenge of maintaining its global production lines during the pandemic without endangering its workforce. Since remote work was not an option, the risk of COVID-19 outbreaks threatened costly shutdowns. To solve this, they turned to Microshare for its Universal Contact Tracing wearables.

Microshare's solution provided wearable devices that track movements within facilities using pseudonymized Bluetooth data, ensuring no personally identifiable information is collected. This approach allowed GlaxoSmithKline to contain and prevent outbreaks, avoiding disruptive shutdowns and protecting workers. The result was that the company could safely stay in production, a critical outcome as even slowing production was stated to cost millions of dollars per week.

GlaxoSmithKline